MX2013012259A - Analogos del factor de liberacion de la hormona de crecimiento (grf) y usos de estos. - Google Patents

Analogos del factor de liberacion de la hormona de crecimiento (grf) y usos de estos.

Info

Publication number
MX2013012259A
MX2013012259A MX2013012259A MX2013012259A MX2013012259A MX 2013012259 A MX2013012259 A MX 2013012259A MX 2013012259 A MX2013012259 A MX 2013012259A MX 2013012259 A MX2013012259 A MX 2013012259A MX 2013012259 A MX2013012259 A MX 2013012259A
Authority
MX
Mexico
Prior art keywords
analogs
grf
growth hormone
releasing factor
hormone releasing
Prior art date
Application number
MX2013012259A
Other languages
English (en)
Spanish (es)
Inventor
Krishna G Peri
Abdelkrim Habi
Original Assignee
Theratechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theratechnologies Inc filed Critical Theratechnologies Inc
Publication of MX2013012259A publication Critical patent/MX2013012259A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MX2013012259A 2011-04-21 2012-04-17 Analogos del factor de liberacion de la hormona de crecimiento (grf) y usos de estos. MX2013012259A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161477775P 2011-04-21 2011-04-21
PCT/CA2012/050242 WO2012142706A1 (en) 2011-04-21 2012-04-17 Growth hormone releasing factor (grf) analogs and uses thereof

Publications (1)

Publication Number Publication Date
MX2013012259A true MX2013012259A (es) 2013-11-22

Family

ID=47021786

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013012259A MX2013012259A (es) 2011-04-21 2012-04-17 Analogos del factor de liberacion de la hormona de crecimiento (grf) y usos de estos.

Country Status (10)

Country Link
US (1) US8361964B2 (enExample)
EP (1) EP2699591A4 (enExample)
JP (1) JP6113144B2 (enExample)
KR (1) KR20140027284A (enExample)
CN (1) CN103547591A (enExample)
AR (1) AR087727A1 (enExample)
BR (1) BR112013027150A2 (enExample)
CA (1) CA2833434A1 (enExample)
MX (1) MX2013012259A (enExample)
WO (1) WO2012142706A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013190520A2 (en) 2012-06-22 2013-12-27 The General Hospital Corporation Gh-releasing agents in the treatment of vascular stenosis and associated conditions
PL3445778T3 (pl) 2016-04-19 2021-02-22 Griffon Pharmaceuticals International Sa Pegylowane bioaktywne peptydy i ich zastosowania
KR20230035600A (ko) * 2020-07-05 2023-03-14 쎄러테크놀로지스 인코포레이티드 Ghrh 유사체의 저-용량 약제학적 조성물 및 이들의 용도

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518586A (en) 1983-01-13 1985-05-21 The Salk Institute For Biological Studies GRF Analogs III
US4617149A (en) 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs
US4622312A (en) 1984-09-24 1986-11-11 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
US4734399A (en) * 1985-08-06 1988-03-29 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
US4801456A (en) 1987-07-09 1989-01-31 International Minerals & Chemical Corp. Growth hormone-releasing factor analogs
EP0307860B1 (en) * 1987-09-18 1994-06-08 F. Hoffmann-La Roche Ag Cyclic GRF-analogs
NZ237857A (en) * 1990-04-24 1992-05-26 Lilly Co Eli Polypeptide compounds with growth hormone releasing factor activity
AU662731B2 (en) 1991-04-09 1995-09-14 F. Hoffmann-La Roche Ag Growth hormone releasing factor analogs
US5262519A (en) 1991-05-15 1993-11-16 The Salk Institute For Biological Studies GRF analogs XI
WO1996032126A1 (en) 1995-04-14 1996-10-17 The Administrators Of The Tulane Educational Fund Analogs of growth hormone-releasing factor
PT828758E (pt) 1995-05-26 2002-02-28 Theratechnologies Inc Analogos quimericos de corpo gordo-pro-grf com potencia biologica aumentada
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
EP0922446A1 (en) 1997-12-03 1999-06-16 Applied Research Systems Ars Holding N.V. Solution-phase site-specific preparation of GRF-PEG conjugates
US6057422A (en) 1998-11-25 2000-05-02 The Administrators Of The Tulane Educational Fund Antagonistic analogs of GH-RH inhibiting IGF-I and -II
IL155177A0 (en) 2000-10-05 2003-11-23 Ares Trading Sa Method for the preparation of grf-peg conjugate
CN101696240A (zh) 2001-02-02 2010-04-21 康久化学生物技术公司 长效生长激素释放因子衍生物
RU2277539C2 (ru) * 2001-06-08 2006-06-10 Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик С.А.С. Химерные аналоги соматостатина-дофамина
WO2004027064A2 (en) 2002-09-18 2004-04-01 Centre Hospitalier De L'universite De Montreal (Chum) Ghrh analogues
CA2527039C (en) 2003-05-29 2013-07-09 Theratechnologies Inc. Grf analog compositions and their use
TW200517400A (en) 2003-08-05 2005-06-01 Univ Tulane Antagonistic analogs of GH-RH (2003)
EP1675610A4 (en) 2003-10-20 2010-04-28 Theratechnologies Inc USE OF GROWTH HORMONE RELEASE FACTOR ANALOGUE IN THE TREATMENT OF PATIENTS WITH EXCEPTION
EP1812048A4 (en) 2004-10-20 2012-01-18 Theratechnologies Inc GH SECRETAGOGA AND ITS USE
US8021859B2 (en) 2005-03-15 2011-09-20 Allergan, Inc. Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
WO2009009727A2 (en) 2007-07-12 2009-01-15 Akela Pharma Srl Ghrh analogs and therapeutic uses thereof
US20110021429A1 (en) 2007-10-01 2011-01-27 Pierrette Gaudreau Renoprotection by growth hormone-releasing hormone and agonists
US20100267636A1 (en) 2009-04-20 2010-10-21 Theratechnologies Inc. Use of cytochrome p450-metabolized drugs and grf molecules in combination therapy

Also Published As

Publication number Publication date
CA2833434A1 (en) 2012-10-26
JP6113144B2 (ja) 2017-04-12
EP2699591A4 (en) 2014-05-07
WO2012142706A1 (en) 2012-10-26
BR112013027150A2 (pt) 2017-06-06
KR20140027284A (ko) 2014-03-06
AR087727A1 (es) 2014-04-16
JP2014515751A (ja) 2014-07-03
EP2699591A1 (en) 2014-02-26
US8361964B2 (en) 2013-01-29
CN103547591A (zh) 2014-01-29
US20120270784A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
NZ612297A (en) Glucagon analogs exhibiting gip receptor activity
MX2013015168A (es) Co-agonista del receptor de glucagon/glp-1.
PH12013502671A1 (en) Glucagon/glp-1 receptor co-agonists
TN2012000567A1 (en) Glucagon analogues
PH12013501136A1 (en) Lysophosphatidic acid receptor antagonists and uses thereof
EP2718317A4 (en) GLUCOSE-DEPENDENT INSULINOTROPE POLYPEPTIDE ANALOGUE, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
NZ631445A (en) Anti-fgfr2 antibody
SG10201906304TA (en) Use of perfusion decellularized liver for islet cell recellularization
TN2012000560A1 (en) Glucagon analogues
PL3111926T3 (pl) Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego
MX2012013232A (es) Analogos de hormona paratiroidea y usos para los mismos.
DOP2012000244A (es) Nuevos péptidos y métodos para su preparación y uso
PH12015502593A1 (en) COMPOSITIONS, METHODS and SYSTEMS FOR RESPIRATORY DELIVERY OF THREE OR MORE ACTIVE AGENTS
TW201144301A (en) Processes for preparing linezolid
WO2012015975A3 (en) Glp-1 receptor agonist compounds having stabilized regions
IL221808B (en) Method for obtaining biologically active recombinant human g-csf
ZA201403189B (en) Method for preparing physiologically active polypeptide complex
EA201301264A1 (ru) Способ получения неорганического материала в виде частиц
EP2682122A4 (en) GROWTH HORMONE SEKRETIONSPROMOTER
IN2013MN00733A (enExample)
PT2916829T (pt) Utilização de material baseado em óxido de silício para a libertação modificada de agentes biologicamente ativos
MX2013012259A (es) Analogos del factor de liberacion de la hormona de crecimiento (grf) y usos de estos.
MX2013011629A (es) Uso de un agente que consiste en anticuerpos y/o antagonistas de factor de crecimiento tipo insulina.
MX2015012905A (es) Formulaciones de factor viii recombinantes.
UA118653C2 (uk) Суперагоністи глікопротеїнового гормону тривалої дії

Legal Events

Date Code Title Description
FG Grant or registration